CBLPath, Inc., a leading provider of diagnostic and laboratory services, is headquartered in the United States, with significant operations across various regions. Founded in 2001, the company has established itself in the healthcare industry, specialising in anatomic pathology, molecular diagnostics, and laboratory testing services. CBLPath is renowned for its commitment to quality and innovation, offering unique products such as advanced diagnostic solutions that enhance patient care. The company has achieved notable milestones, including accreditation from prestigious organisations, which underscores its market position as a trusted partner in the healthcare sector. With a focus on precision and reliability, CBLPath continues to set benchmarks in diagnostic excellence, making it a preferred choice for healthcare providers nationwide.
How does CBLPath, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
CBLPath, Inc.'s score of 66 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
CBLPath, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Sonic Healthcare Limited, which may influence its climate commitments and reporting practices. As of now, CBLPath, Inc. has not established any documented reduction targets or climate pledges. The absence of specific initiatives or targets suggests that the company may be in the early stages of developing its climate strategy or relies on the broader commitments of its parent organisation. Given the lack of direct emissions data and reduction initiatives, CBLPath, Inc. appears to be aligned with the climate commitments of Sonic Healthcare Limited, which may include industry-standard practices and targets. However, without explicit data or commitments from CBLPath, Inc. itself, a detailed assessment of its carbon emissions and climate strategy remains unclear.
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 8,124,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 
| Scope 2 | 59,156,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 
CBLPath, Inc.'s Scope 3 emissions, which increased by 13% last year and increased by approximately 1% since 2021, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 43% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CBLPath, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.